Renaissance Technologies
LNAI

Renaissance Technologies’s Lunai Bioworks LNAI Stock Holding History

Renaissance Technologies’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,720
Closed -$53.6K – 3672
2025
Q3 		$53.6K Buy
+4,720
New +$91K ﹤0.01% 3330
2022
Q1 		– Sell
-1,129
Closed -$659K – 4392
2021
Q4 		$659K Buy
+1,129
New +$820K ﹤0.01% 2939
2021
Q1 		– Sell
-693
Closed -$163K – 3634
2020
Q4 		$163K Buy
+693
New +$175K ﹤0.01% 3181
2020
Q1 		– Sell
-144
Closed -$58K – 3728
2019
Q4 		$58K Buy
+144
New +$63.3K ﹤0.01% 3378

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $995M AUM 22.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Renaissance Technologies's LNAI Position: Q4 2025 in Review

Renaissance Technologies sold out of Lunai Bioworks (LNAI) in Q4 2025, closing a stake of 4,720 shares — an estimated $53.6K sold.

Renaissance Technologies first reported a position in LNAI in Q4 2019 and held it in 4 quarters. The position peaked at $659K in Q4 2021. 22 funds tracked by Wall St. Rank hold LNAI as of Q4 2025.

  • Renaissance Technologies reported no remaining Lunai Bioworks position as of Q4 2025 after selling out during the quarter.
  • Renaissance Technologies sold 4,720 Lunai Bioworks shares in Q4 2025, an estimated $53.6K.
  • Renaissance Technologies first reported a position in Lunai Bioworks in Q4 2019 and held it in 4 quarters.
  • Renaissance Technologies's Lunai Bioworks position peaked at $659K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.